116 related articles for article (PubMed ID: 8045673)
1. Tumor necrosis factor release by murine macrophages stimulated by the cytotoxic ether lipid 1-O-hexadecyl-2-O-methyl-SN-glycero-3-phosphorylcholine (ET-18-O-OCH3).
Shames R; Ruis NM; Valone FH
Int J Immunopharmacol; 1994 Apr; 16(4):335-43. PubMed ID: 8045673
[TBL] [Abstract][Full Text] [Related]
2. Two different sites of action for platelet activating factor and 1-O-alkyl-2-O-methyl-sn-glycero-3-phosphocholine on platelets and leukemic cells.
Salari H; Dryden P; Howard S; Bittman R
Biochem Cell Biol; 1992 Feb; 70(2):129-35. PubMed ID: 1324692
[TBL] [Abstract][Full Text] [Related]
3. 1-O-hexadecyl-2-metoxy-glycero-3-phosphatidylcholine--a methoxy ether lipid inhibiting platelet activating factor-induced platelet aggregation and neutrophil oxidative metabolism.
Le Blanc K; Samuelsson J; Brohult J; Berg A; Palmblad J
Biochem Pharmacol; 1995 May; 49(11):1577-82. PubMed ID: 7786298
[TBL] [Abstract][Full Text] [Related]
4. The induction and augmentation of macrophage tumoricidal responses by platelet-activating factor.
Howard AD; Erickson KL
Cell Immunol; 1995 Aug; 164(1):105-12. PubMed ID: 7634340
[TBL] [Abstract][Full Text] [Related]
5. Activation of guinea pig peritoneal macrophages by platelet activating factor (PAF) and its agonists.
Hayashi H; Kudo I; Inoue K; Onozaki K; Tsushima S; Nomura H; Nojima S
J Biochem; 1985 Jun; 97(6):1737-45. PubMed ID: 2993272
[TBL] [Abstract][Full Text] [Related]
6. The degradation of platelet-activating factor and related lipids: susceptibility to phospholipases C and D.
Wilcox RW; Wykle RL; Schmitt JD; Daniel LW
Lipids; 1987 Nov; 22(11):800-7. PubMed ID: 3444369
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor release by human monocytes stimulated with platelet-activating factor.
Ruis NM; Rose JK; Valone FH
Lipids; 1991 Dec; 26(12):1060-4. PubMed ID: 1668105
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of tumour necrosis factor release by cytotoxic analogues of platelet-activating factor.
Valone FH; Ruis NM
Immunology; 1992 May; 76(1):24-9. PubMed ID: 1628897
[TBL] [Abstract][Full Text] [Related]
9. Selective activation of human monocytes by the platelet-activating factor analog 1-O-hexadecyl-2-O-methyl-sn-glycero-3-phosphorylcholine.
Rose JK; Debs RA; Philip R; Ruis NM; Valone FH
J Immunol; 1990 May; 144(9):3513-7. PubMed ID: 2329280
[TBL] [Abstract][Full Text] [Related]
10. Biological response of guinea pig peritoneal macrophages to platelet-activating factor.
Hayashi H; Kudo I; Nojima S; Inoue K
Lipids; 1991 Dec; 26(12):1193-9. PubMed ID: 1668117
[TBL] [Abstract][Full Text] [Related]
11. Influence of platelet activating factor and a nonmetabolizable analogue on superoxide production by bone marrow derived macrophages.
Storch J; Ferber E; Munder PG
J Leukoc Biol; 1988 Nov; 44(5):385-90. PubMed ID: 2846728
[TBL] [Abstract][Full Text] [Related]
12. Alteration of platelet-activating factor-induced signal transduction in macrophages by n-3 fatty acids.
Chakrabarti R; Hubbard NE; Lim D; Erickson KL
Cell Immunol; 1997 Jan; 175(1):76-84. PubMed ID: 9015191
[TBL] [Abstract][Full Text] [Related]
13. Meconium enhances platelet-activating factor and tumor necrosis factor production by rat alveolar macrophages.
Berdeli A; Akisu M; Dagci T; Akisu C; Yalaz M; Kultursay N
Prostaglandins Leukot Essent Fatty Acids; 2004 Oct; 71(4):227-32. PubMed ID: 15301793
[TBL] [Abstract][Full Text] [Related]
14. 1-O-hexadecyl-2-acetyl-sn-glycero-3-phospho (N,N,N trimethyl) hexanolamine: an analogue of platelet-activating factor with partial agonist activity.
Grigoriadis G; Stewart AG
Br J Pharmacol; 1991 Sep; 104(1):171-7. PubMed ID: 1664761
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.
Ring PC; Seldon PM; Barnes PJ; Giembycz MA
Mol Pharmacol; 1993 Feb; 43(2):302-12. PubMed ID: 8381515
[TBL] [Abstract][Full Text] [Related]
16. 1-O-hexadecyl-2-O-methyl-sn-glycero-3-phosphocholine inhibits diacylglycerol kinase in WEHI-3B cells.
Salari H; Low M; Howard S; Edin G; Bittman R
Biochem Cell Biol; 1993; 71(1-2):36-42. PubMed ID: 8392354
[TBL] [Abstract][Full Text] [Related]
17. The effect of ether lipid 1-O-octadecyl-2-O-methoxy-rac-glycero-3-phosphocholine and its analogues platelet activating factor and carbamyl-platelet activating factor on the biosynthesis of interleukin-6 in human thymic epithelial cells cultivated in vitro.
Cardile V; Mascarucci P; De Simoni MG; Jiang X; Bindoni M
Cytokine; 1996 Sep; 8(9):698-701. PubMed ID: 8932980
[TBL] [Abstract][Full Text] [Related]
18. A Penicillium sp. F33 metabolite and its synthetic derivatives inhibit acetyl-CoA:1-O-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and carrageenan-induced paw edema in mice.
Yamazaki Y; Yasuda K; Matsuyama T; Ishihara T; Higa R; Sawairi T; Yamaguchi M; Egi M; Akai S; Miyase T; Ikari A; Miwa M; Sugatani J
Biochem Pharmacol; 2013 Sep; 86(5):632-44. PubMed ID: 23817078
[TBL] [Abstract][Full Text] [Related]
19. The ether lipid ET-18-OCH3 increases cytosolic Ca2+ concentrations in Madin Darby canine kidney cells.
Jan CR; Wu SN; Tseng CJ
Br J Pharmacol; 1999 Jul; 127(6):1502-10. PubMed ID: 10455302
[TBL] [Abstract][Full Text] [Related]
20. ET-18-OCH3 inhibits nuclear factor-kappa B activation by 12-O-tetradecanoylphorbol-13-acetate but not by tumor necrosis factor-alpha or interleukin 1 alpha.
Daniel LW; Civoli F; Rogers MA; Smitherman PK; Raju PA; Roederer M
Cancer Res; 1995 Nov; 55(21):4844-9. PubMed ID: 7585518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
